Correlation Between QuantumKore and Hikma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both QuantumKore and Hikma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining QuantumKore and Hikma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between QuantumKore and Hikma Pharmaceuticals PLC, you can compare the effects of market volatilities on QuantumKore and Hikma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in QuantumKore with a short position of Hikma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of QuantumKore and Hikma Pharmaceuticals.
Diversification Opportunities for QuantumKore and Hikma Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between QuantumKore and Hikma is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding QuantumKore and Hikma Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hikma Pharmaceuticals PLC and QuantumKore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on QuantumKore are associated (or correlated) with Hikma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hikma Pharmaceuticals PLC has no effect on the direction of QuantumKore i.e., QuantumKore and Hikma Pharmaceuticals go up and down completely randomly.
Pair Corralation between QuantumKore and Hikma Pharmaceuticals
Given the investment horizon of 90 days QuantumKore is expected to generate 9.7 times more return on investment than Hikma Pharmaceuticals. However, QuantumKore is 9.7 times more volatile than Hikma Pharmaceuticals PLC. It trades about 0.14 of its potential returns per unit of risk. Hikma Pharmaceuticals PLC is currently generating about 0.06 per unit of risk. If you would invest 30.00 in QuantumKore on November 2, 2024 and sell it today you would earn a total of 70.00 from holding QuantumKore or generate 233.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.04% |
| Values | Daily Returns |
QuantumKore vs. Hikma Pharmaceuticals PLC
Performance |
| Timeline |
| QuantumKore |
| Hikma Pharmaceuticals PLC |
QuantumKore and Hikma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with QuantumKore and Hikma Pharmaceuticals
The main advantage of trading using opposite QuantumKore and Hikma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if QuantumKore position performs unexpectedly, Hikma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hikma Pharmaceuticals will offset losses from the drop in Hikma Pharmaceuticals' long position.| QuantumKore vs. Universal Systems | QuantumKore vs. AAP Inc | QuantumKore vs. Cascadero Copper | QuantumKore vs. Arrow Exploration Corp |
| Hikma Pharmaceuticals vs. Viatris | Hikma Pharmaceuticals vs. Bausch Health Companies | Hikma Pharmaceuticals vs. Tilray Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |